JACOB GARY S (Chief Executive Officer) received a stock award from OKYO PHARMA LTD
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/23/2026ACC: 0001493152-26-034406
DirectorOfficer· Chief Executive Officer
Since May 2022
+3.50K
Net shares
Net buyer
$4.9K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
3.50K acquired
Non-Derivative Transactions1
COMMON STOCK
Direct
Shares
+3.50K
Price / share
$1.40
Trade value
$4.90K
% of position
3.2%
7/21/2026
108.92K→112.42K
Total
Net shares
+3.50K
Net value
$4.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK Direct | 7/21/2026 | A · Award | +3.50K | $1.40 | $4.90K | 3.2% | 108.92K | 112.42K |
| Total | +3.50K | $4.90K | ||||||
Derivative Transactions0
No derivative transactions reported